DEVONIAN HEALTH GROUP INC (GSD.CA) Stock Price, Quote, News and Overview
TSX-V:GSD - TSX Venture Exchange - CA2518348008 - Common Stock - Currency: CAD
GSD.CA Quote, Performance and Key Statistics
TSX-V:GSD (3/7/2025, 7:00:00 PM)
0.185
0 (0%)
The current stock price of GSD.CA is 0.185 CAD. In the past month the price increased by 8.82%. In the past year, price decreased by -7.5%.
GSD.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.87 | 3.77B | ||
| CRON.CA | CRONOS GROUP INC | N/A | 1.08B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 928.28M | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 4.93 | 675.16M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 546.47M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 3.62 | 495.53M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 376.34M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 293.01M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 12.54 | 288.91M | ||
| HITI.CA | HIGH TIDE INC | N/A | 278.36M | ||
| TSND.CA | TERRASCEND CORP | N/A | 249.63M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 198.02M |
Related stock screener links
About GSD.CA
Company Profile
Devonian Health Group Inc is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Montmagny, Quebec and currently employs 6 full-time employees. The company went IPO on 2014-09-09. Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The firm is focused on developing prescription botanical drugs from plant materials and algae for the treatment of inflammatory autoimmune diseases, including but not limited to ulcerative colitis and atopic dermatitis. The company is also involved in the development of high-value cosmeceutical products leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health conditions related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., is focused on selling prescription pharmaceutical products in Canada, under license from brand name pharmaceutical companies.
Company Info
DEVONIAN HEALTH GROUP INC
360 rue des Entrepreneurs
Montmagny QUEBEC G5V 4T1 CA
CEO: Andre P. Boulet
Employees: 7
Company Website: https://groupedevonian.com/
Investor Relations: http://www.groupedevonian.com/investor-center/financial-reports/
Phone: 15142487509
DEVONIAN HEALTH GROUP INC / GSD.CA FAQ
What is the stock price of DEVONIAN HEALTH GROUP INC today?
The current stock price of GSD.CA is 0.185 CAD.
What is the ticker symbol for DEVONIAN HEALTH GROUP INC stock?
The exchange symbol of DEVONIAN HEALTH GROUP INC is GSD and it is listed on the TSX Venture Exchange exchange.
On which exchange is GSD.CA stock listed?
GSD.CA stock is listed on the TSX Venture Exchange exchange.
What is DEVONIAN HEALTH GROUP INC worth?
DEVONIAN HEALTH GROUP INC (GSD.CA) has a market capitalization of 27.42M CAD. This makes GSD.CA a Nano Cap stock.
How many employees does DEVONIAN HEALTH GROUP INC have?
DEVONIAN HEALTH GROUP INC (GSD.CA) currently has 7 employees.
What are the support and resistance levels for DEVONIAN HEALTH GROUP INC (GSD.CA) stock?
DEVONIAN HEALTH GROUP INC (GSD.CA) has a support level at 0.14 and a resistance level at 0.25. Check the full technical report for a detailed analysis of GSD.CA support and resistance levels.
Should I buy DEVONIAN HEALTH GROUP INC (GSD.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GSD.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GSD.CA, evaluating the profitability, health, valuation and growth aspects
- DEVONIAN HEALTH GROUP INC (GSD.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DEVONIAN HEALTH GROUP INC (GSD.CA) Sales and EPS estimates to see what analysts future expectations are.
- DEVONIAN HEALTH GROUP INC (GSD.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DEVONIAN HEALTH GROUP INC (GSD.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- DEVONIAN HEALTH GROUP INC (GSD.CA) Stock Chart to make your own analysis
- DEVONIAN HEALTH GROUP INC (GSD.CA) Latest news and press-releases to stay up to date.
Does DEVONIAN HEALTH GROUP INC (GSD.CA) stock pay dividends?
GSD.CA does not pay a dividend.
When does DEVONIAN HEALTH GROUP INC (GSD.CA) report earnings?
DEVONIAN HEALTH GROUP INC (GSD.CA) will report earnings on 2025-03-25.
What is the Price/Earnings (PE) ratio of DEVONIAN HEALTH GROUP INC (GSD.CA)?
DEVONIAN HEALTH GROUP INC (GSD.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
GSD.CA Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to GSD.CA. When comparing the yearly performance of all stocks, GSD.CA turns out to be only a medium performer in the overall market: it outperformed 65.74% of all stocks.
GSD.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GSD.CA. GSD.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
GSD.CA Financial Highlights
Over the last trailing twelve months GSD.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 80.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.59% | ||
| ROE | -5.96% | ||
| Debt/Equity | 0.01 |